Log in to save to my catalogue

NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced...

NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2387514827

NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress

About this item

Full title

NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress

Publisher

Atlanta: NewsRx

Journal title

Medical Letter on the CDC & FDA, 2020, p.605

Language

English

Publication information

Publisher

Atlanta: NewsRx

More information

Alternative Titles

Full title

NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2387514827

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2387514827

Other Identifiers

E-ISSN

1532-4648

How to access this item